Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 18,505 | 17,559 | 17,227 | 45,220 | 13,848 |
| Operating Income | -18,505 | -17,559 | -17,227 | -45,220 | -13,848 |
| Interest Expense | 0 | 0 | 0 | 0 | 87 |
| Other Income | 54 | -427 | 31 | -32 | 176 |
| Pre-tax Income | -18,451 | -17,986 | -17,196 | -45,252 | -13,759 |
| Net Income Continuous | -18,451 | -16,829 | -17,196 | -45,252 | -13,759 |
| Net Income | $-18,451 | $-16,829 | $-17,196 | $-45,252 | $-13,759 |
| EPS Basic Total Ops | -0.66 | -0.54 | -0.61 | -1.65 | -0.60 |
| EPS Basic Continuous Ops | -0.66 | -0.60 | -0.61 | -1.65 | -0.53 |
| EPS Diluted Total Ops | -0.66 | -0.54 | -0.61 | -1.65 | -0.60 |
| EPS Diluted Continuous Ops | -0.66 | -0.60 | -0.61 | -1.65 | -0.53 |
| EBITDA(a) | $-17,725 | $-16,771 | $-16,438 | $-44,441 | $-13,588 |